Form 4 Tracker
Anika Therapeutics, Inc.
ANIK

17 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 1, 2026May 4 12:34 PMJohn B Henneman IIIDirector
Purchase
5,000$14.66$73.3K54,871(D)

View →

Apr 30, 2026Apr 30 9:22 PMStephen D. GriffinDirector, President and CEO
Purchase
12,200$12.29$149.9K36,163(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 5 8:05 PMStephen D. GriffinDirector, President and CEO
Option Exercise
12,84012,840(D)

View →

Mar 19, 2026Mar 23 9:23 PMIan McleodSVP, CAO & Treasurer
Grant/Award
41,954$15.6017,663(D)

View →

Mar 15, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
6,4496,448(D)

View →

Mar 14, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
9,38818,777(D)

View →

Mar 14, 2026Mar 17 11:44 PMStephen D. GriffinDirector, President and CEO
Option Exercise
12,82425,649(D)

View →

Mar 15, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
25,13125,132(D)

View →

Mar 14, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
24,51949,040(D)

View →

Mar 15, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,6582,659(D)

View →

Mar 14, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
3,7747,550(D)

View →

Mar 9, 2026Mar 11 8:25 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
5,4650(D)

View →

Mar 9, 2026Mar 11 8:24 PMCheryl R BlanchardDirector
Option Exercise
20,0010(D)

View →

Mar 9, 2026Mar 11 8:24 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,1970(D)

View →

Feb 1, 2026Feb 3 11:45 PMStephen D. GriffinDirector, President and CEO
Grant/Award
440,609130,402(D)

View →